Evidence map›Paper›PMID 16385110›Full record

ReviewMicrobiology (Reading, England)2006

Phenotypic switching in Cryptococcus neoformans.

A Guerrero, N Jain, D L Goldman, B C Fries

Open access · greenAbstract readReview
In one paragraph

Review in Microbiology (Reading, England), 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Article
  3. Mechanisms and Virulence Factors ofJournal of fungi (Basel, Switzerland) · 2024
    Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Incorporation of 2-amino-thiophene derivative in nanoparticles: enhancement of antifungal activity.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2020
    Article
  9. Article
  10. Antifungal activity of topical microemulsion containing a thiophene derivative.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2014
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

A GuerreroDepartments of Microbiology and Immunology at All India Institute of Medical Sciences, New Delhi, India.
N JainDepartment of Microbiology at All India Institute of Medical Sciences, New Delhi, India.
D L GoldmanDepartment of Pediatrics, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
B C FriesDepartment of Medicine, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
Albert Einstein College of Medicine · USAll India Institute of Medical Sciences · IN

Funding

INTERNATIONAL TRAINING IN AIDS/TB PREVENTION RESEARCHD43TW001403 · FIC · YESHIVA UNIVERSITY · PI PRASAD, VINAYAKA R. · 2000 to 2011
$3.8M
response to phenotypic switch variants to C. neoformansR01AI059681 · NIAID · STATE UNIVERSITY NEW YORK STONY BROOK · PI FRIES, BETTINA · 2004 to 2014
$3.6M
FIC NIH HHS D43 TW001403FIC NIH HHS D43-TW01403NIAID NIH HHS R01 AI059681NIAID NIH HHS R0-1 AI 59681
6 · The paper itself

Abstract

Phenotypic switching has been described in serotype A and D strains of Cryptococcus neoformans. It occurs in vivo during chronic infection and is associated with differential gene expression and changes in virulence. The switch involves changes in the polysaccharide capsule and cell wall that affect the yeast's ability to resist phagocytosis. In addition, the phenotypic switch variants elicit qualitatively different inflammatory responses in the host. In animal models of chronic cryptococosis, the immune response of the host ultimately determines which of the switch variants are selected and maintained. The importance of phenotypic switching is further underscored by several findings that are relevant in the setting of human disease. These include the ability of the mucoid colony variant of RC-2 (RC-2 MC) but not the smooth variant (RC-2 SM) to promote increased intracerebral pressure in a rat model of cryptococcal meningitis. Furthermore, chemotherapeutic and immunological antifungal interventions can promote the selection of the RC-2 MC variant during chronic murine infection.

Indexed as

AnimalsBacterial CapsulesChronic DiseaseCryptococcosisCryptococcus neoformansGenes, BacterialGenetic VariationHumansIntracranial PressureMeningitis, CryptococcalMicePhagocytosisPolysaccharidesRatsSelection, GeneticVirulencePolysaccharides

Identifiers

PMID16385110
PMCPMC2721797
OpenAlexW1963835180

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.